| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00452387 Details | 2011-09-16 Interventional | 2 | 22 | Mitoxantrone Prednisone Sorafenib Prostatic Neopl… Metastatic Pros… | Early stopping rule Early termination, according to the stopping rule included in the protocol, leading to a small number of subjects analyzed | |||
| NCT01242579 Details | 2011-09-09 Interventional | 1 | 0 | Dapivirine Maraviroc HIV Infections | In order to focus efforts on the combination ring formulation, IPM decided not to move forward
with this trial. - | |||
| NCT01299415 Details | 2011-09-02 Interventional | 1 | 17 | Vadimezan Solid Tumors | - - | |||
| NCT01290380 Details | 2011-09-02 Interventional | 1 | 54 | Vadimezan Neoplasms Solid Tumor Mal… | - - | |||
| NCT00430443 Details | 2011-08-31 Interventional | 1 | 3 | Annamycin Leukemia Leukemia, Lymph… Leukemia, Myelo… Leukemia, Myelo… Precursor Cell … Acute Lymphocyt… Acute Myelogeno… | Participants are no longer being examined or treated. - | |||
| NCT00402376 Details | 2011-08-30 Interventional | 4 | - | Carvedilol Perindopril Pravastatin Heart Failure | - - | |||
| NCT00286936 Details | 2011-08-30 Interventional | 4 | - | Zolpidem Delirium Fractures, Bone Hip Fractures Hip Fracture | Slow inclusion resulting in premature termination due to logistics - | |||
| NCT00229684 Details | 2011-08-30 Interventional | 2 | - | Pioglitazone Diabetes Mellit… Diabetes Mellit… | The development program has been terminated - | |||
| NCT00903838 2008-000400-81 Details | 2011-08-26 Interventional | 2 | 37 | Dexpramipexole Pramipexole Dyskinesias Parkinson Disea… Advanced Stage … | The study was terminated on 31 May, 2011, due to strategic considerations. - | |||
| NCT00562887 2008-004919-36 Details | 2011-08-23 Interventional | 2 | 246 | Antibodies, Mon… Crohn Disease Crohn's Disease | - - | |||
| NCT01406704 Details | 2011-08-19 Interventional | 4 | 26 | Rosiglitazone Thioctic Acid Fatty Liver Hepatitis Non-alcoholic F… NASH (Non-alcoh… | because of withdrawal of Avandia sale due to its risks outweigh its benefits - | |||
| NCT00857259 2008-003550-15 Details | 2011-08-19 Interventional | 2 | 16 | Everolimus Ranibizumab Macular Degener… Age-related Mac… Choroidal Neo-V… | - - | |||
| NCT00915811 2006-004452-20 Details | 2011-08-17 Interventional | 2 | - | Antilymphocyte … Busulfan Fludarabine Thymoglobulin Leukemia Leukemia, Myelo… Leukemia, Myelo… Myelodysplastic… Preleukemia Syndrome | FB ATG is now a standard for sib allo MDS patients - | |||
| NCT01416883 Details | 2011-08-15 Interventional | 1 | 8 | Bicalutamide Healthy | - - | |||
| NCT00528593 Details | 2011-08-09 Interventional | 2 | 0 | Epoetin Alfa Peripheral Nerv… HIV Infections Neuropathy | lack of pharmaceutical support - | |||
| NCT01408836 Details | 2011-08-03 Interventional | 2/3 | 150 | Methylprednisol… Methylprednisol… Methylprednisol… Prednisolone Prednisolone ac… Prednisolone he… Prednisolone ph… Granulomatosis … Microscopic Pol… Vasculitis Wegener's Granu… | Completed - | |||
| NCT01408589 Details | 2011-08-03 Interventional | 1 | 86 | Atomoxetine Hyd… Alcohol Craving Mood Changes | - - | |||
| NCT01202513 Details | 2011-08-03 Interventional | 4 | 20 | Bimatoprost Ophthalmic Solu… Vitiligo Repigmentation | regulatory reasons - | |||
| NCT00992732 Details | 2011-08-01 Interventional | 2 | 1 | Arginine butyra… Ganciclovir Ganciclovir tri… Valganciclovir Epstein-Barr Vi… Lymphoprolifera… Neoplasms Lymphoid Malign… | - - | |||
| NCT00917826 Details | 2011-08-01 Interventional | 2 | 1 | Arginine butyra… Ganciclovir Ganciclovir tri… Valganciclovir Lymphoprolifera… EBV Lymphomas Lympho-prolifer… | - - |